Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Electron Kebebew

Showing results (111-120 of 378) with videos related to

Pageof 38
Sort By:
Annals of Surgical Oncology|November 15, 2017
Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective AnalysisApostolos Gaitanidis, Dhaval Patel, Naris Nilubol, et al.
Cancer|April 8, 2011
MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancyErin E Patterson, Alisha K Holloway, Julie Weng, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|April 9, 2020
Surgery for adrenocortical carcinoma: When and how?Tiffany J Sinclair, Andrea Gillis, Wilson M Alobuia, et al.
Annals of Surgery|November 19, 2014
Total 18F-FDG PET/CT Metabolic Tumor Volume Is Associated With Postoperative Biochemical Response in Patients With Metastatic Pheochromocytomas and ParagangliomasDhaval Patel, Amit Mehta, Naris Nilubol, et al.
Experimental Dermatology|June 5, 2009
Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancerJürgen Bauer, Julie Weng, Electron Kebebew, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 23, 2006
Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive casesWen T Shen, James Lee, Electron Kebebew, et al.
Journal of Surgical Oncology|November 17, 2019
Preoperative systemic inflammatory markers are prognostic indicators in recurrent adrenocortical carcinomaApostolos Gaitanidis, Douglas Wiseman, Mustapha El Lakis, et al.
Cancer|March 2, 2005
Anaplastic thyroid carcinoma. Treatment outcome and prognostic factorsElectron Kebebew, Francis S Greenspan, Orlo H Clark, et al.
Annals of Surgery|October 31, 2013
The presence of SDHB mutations should modify surgical indications for carotid body paragangliomasRyan J Ellis, Dhaval Patel, Tamara Prodanov, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 24, 2017
Lipofuscin Accumulation in Cortisol-Producing Adenomas With and Without PRKACA MutationsAnna Angelousi, Eva Szarek, Vincent Shram, et al.
Pageof 38

Showing results (111-120 of 378) with videos related to

Sort By:
Pageof 38
Annals of Surgical Oncology|November 15, 2017
Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective AnalysisApostolos Gaitanidis, Dhaval Patel, Naris Nilubol, et al.
Cancer|April 8, 2011
MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancyErin E Patterson, Alisha K Holloway, Julie Weng, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|April 9, 2020
Surgery for adrenocortical carcinoma: When and how?Tiffany J Sinclair, Andrea Gillis, Wilson M Alobuia, et al.
Annals of Surgery|November 19, 2014
Total 18F-FDG PET/CT Metabolic Tumor Volume Is Associated With Postoperative Biochemical Response in Patients With Metastatic Pheochromocytomas and ParagangliomasDhaval Patel, Amit Mehta, Naris Nilubol, et al.
Experimental Dermatology|June 5, 2009
Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancerJürgen Bauer, Julie Weng, Electron Kebebew, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 23, 2006
Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive casesWen T Shen, James Lee, Electron Kebebew, et al.
Journal of Surgical Oncology|November 17, 2019
Preoperative systemic inflammatory markers are prognostic indicators in recurrent adrenocortical carcinomaApostolos Gaitanidis, Douglas Wiseman, Mustapha El Lakis, et al.
Cancer|March 2, 2005
Anaplastic thyroid carcinoma. Treatment outcome and prognostic factorsElectron Kebebew, Francis S Greenspan, Orlo H Clark, et al.
Annals of Surgery|October 31, 2013
The presence of SDHB mutations should modify surgical indications for carotid body paragangliomasRyan J Ellis, Dhaval Patel, Tamara Prodanov, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 24, 2017
Lipofuscin Accumulation in Cortisol-Producing Adenomas With and Without PRKACA MutationsAnna Angelousi, Eva Szarek, Vincent Shram, et al.
Pageof 38